Skip to main content
. 2017 Dec 15;8(70):115315–115325. doi: 10.18632/oncotarget.23258

Figure 4. The effect of gemcitabine on ISGs.

Figure 4

HeLa cells were treated with various concentrations of gemcitabine (A) or IFN-α (B). After 24 hours, cellular RNAs were isolated and the expression levels of 5 ISGs (CXCL10, IRF7, IRF9, IFIT1 and DDX58) were quantified using real-time PCR. Results were normalized as a percentage relative to DMSO-treated cells. The average and standard deviation were obtained from three independent experiments.